NEW YORK (GenomeWeb) – Foundation Medicine reported after the close of the market on Monday that its 2015 first quarter revenues rose 68 percent year over year.

The Cambridge, Massachusetts-based cancer genomic analysis firm reported total revenues of $19.3 million for the three months ended March 31, up from $11.5 million in the first quarter of 2014. It fell short of the consensus Wall Street estimate of $21 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

CNN reports that researchers have tied a new variant to opioid addiction risk.

Organoids derived from patients' tumors may help determine what chemotherapy treatment patients would benefit from, according to New Scientist.

An initiative from GenomeAsia 100K hopes to increase the number of South Asians in genetic research, according to NBC News.

In Science this week: genomic analysis of ancient and modern horses indicates population turnover, and more.